Lung cancer cells’ survival gene seen as drug target
December 24th, 2007
One of the deadliest forms of cancer appears to carry a specific weakness.
When a key gene called 14-3-3zeta is silenced, lung cancer cells can’t survive on their own, researchers have found.
The gene is a potential target for selective anti-cancer drugs, says Haian Fu, PhD, professor of pharmacology, hematology & oncology at Emory University School of Medicine and Emory Winship Cancer Institute.